Pacific Edge (PEB) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASX
Google NewsInside Pacific Edge’s (ASX:PEB) Latest Price Move and the Diagnostics Theme Investors Are Watching - Kalkine
Inside Pacific Edge’s (ASX:PEB) Latest Price Move and the Diagnostics Theme Investors Are Watching Kalkine
Q1 27 Pacific Edge APAC Operations Advance Towards Profit
earnings announcement
Is Pacific Edge (ASX: PEB) an ASX Healthcare Stock Worth Following? - Kalkine
Is Pacific Edge (ASX: PEB) an ASX Healthcare Stock Worth Following? Kalkine
Notification regarding unquoted securities - PEB
other announcement
NZX Capital Change Notice - Pacific Edge Limited
other announcement
PEB Completes Oversubscribed NZ$36.1m Capital Raise
other announcement
KalkinePacific Edge (ASX:PEB) Medicare Win Sparks Fresh Buzz
Highlights Pacific Edge secured a major US Medicare-related breakthrough tied to cancer diagnostics. The development strengthened discussion around the company’s profitability pathway. Global healthcare diagnostics demand continues lifting attention on precision medicine businesses. Pacific Edge gained renewed attention after a significant Medicare-related breakthrough strengthened discussion around its diagnostics expansion strategy and the growing role of precision medicine in g...
Pacific Edge's (ASX:PEB) Medicare LCD for Cxbladder has landed, and the commercial maths have been rewritten - Stocks Down Under
Pacific Edge's (ASX:PEB) Medicare LCD for Cxbladder has landed, and the commercial maths have been rewritten Stocks Down Under
Advancing Medicare Coverage Goals Cost Contained
other announcement
SPH Notice - ANZ New Zealand Investments Limited
other announcement
Pacific Edge Expands Funding Base as Healthcare Competition Intensifies
Highlights Pacific Edge expanded its quoted share base through a major placement aimed at strengthening financial flexibility The capital raise reinforced ongoing funding activity across the competitive diagnostics and healthcare technology sector Rising demand for precision diagnostics and personalised healthcare continues reshaping medical testing markets globally Pacific Edge expanded its capital base as diagnostics innovation and healthcare technology transformation continued reshaping me...
Draft LCD Proposes Medicare Coverage for Triage and Triage
other announcement
Pacific Edge Placement Increased to NZ$25.4 Million
capital_raise announcement
Pacific Edge FY26 Result to be Announced 25 May 2026
other announcement
Pacific Edge Launches NZ$24 Million Capital Raise
other announcement
Small CapsQ4 26 Test Volumes Rise with Medicare Policy Momentum
other announcement
Leading Singapore Hospital Now Ordering Cxbladder
other announcement
Panel Expresses Support for Urine-Based Biomarkers
other announcement
Medicare Contractor Novitas Schedules Expert Panel
other announcement
Notification regarding unquoted securities - PEB
other announcement
NZX Capital Change Notice - Issue of Options and Shares
other announcement
Pacific Edge Names Simon Flood Chairman Designate
other announcement
Interim Financial Result to be Announced 25 November 2025
other announcement
Q2 26 Cxbladder Volumes Weaken After Coverage Loss
other announcement